Catalog No.Inhibitor Name SrcLckFynLynYesOther
Abl,c-Kit (D816V),c-Kit (wt)
EGFR (L861Q),c-YES,EGFR (L858R)
A16320Dasatinib Monohydrate
Abl ,c-Kit (D816V),c-Kit (wt)
A12417MLR 1023
c-Abl, CDK2, CAMK II
A13819TG 100801
A13820TG 100572
A13868PD 166285

1.Hover mouse over " * " to view the IC50 value.(A few compounds have proven potency but without published IC50 data.)
2.For more details about the compound, click on the product name of your interest.
3.The higher the number of " * " is, the more potent the inhibitor or activator is.
4."" refers to compounds which do inhibitory effects on the related isoform, but without specific value.

39 Item(s)

per page

Set Ascending Direction
  1. KIN001-051

    Catalog No. A16923
    Lck inhibitor
    KIN001-051 is a potent and selective inhibitor of lck. Lymphocyte-speci?c protein tyrosine kinase (Lck) is a member of the Src-family of non-receptor protein tyrosine kinases and plays a critical role in the initial steps of T cell receptor signaling that trigger the production of cytokines. Learn More
  2. MLR 1023

    Catalog No. A12417
    MLR 1023 is a selective allosteric activator of Lyn kinase (EC50 = 63 nM) Learn More
  3. PP1

    Catalog No. A12724
    Src Inhibitor
    PP1 is a potent inhibitor of Src-family tyrosine kinases. Inhibits p56lck and p59fynT (IC50 values are 5 and 6 nM respectively). Displays > 8000-fold selectivity over ZAP-70 and JAK2. Also moderately inhibits p38, CSK, PDGF receptors, RET-derived oncoproteins, c-Kit and Bcr-Abl Learn More
  4. PP2

    Catalog No. A12723
    Src Inhibitor
    PP2 is a selective inhibitor of Src-family tyrosine kinases. Inhibits p56lck and p59fynT (IC50 values are 4 and 5 nM respectively). Displays > 10000-fold selectivity over ZAP-70 and JAK2. Moderately inhibits CSK (IC50 = 0.73 μM). Learn More
  5. XL-228

    Catalog No. A13069
    IGF-1R, Aurora, FGFR, ABL, SRC inhibitor
    XL228 is a protein kinase inhibitor targeting IGF1R, the AURORA kinases, FGFR1-3, ABL and SRC family kinases. XL228 is an Aurora A inhibitor (IC50, f3 nmol/L) that has shown potent biochemical activity against ABL1 (Ki, 5 nmol/L), as well as the BCR-ABL1 T315I (Ki, 1.4 nmol/L) kinases. Learn More
  6. 1-NA-PP1

    Catalog No. A13232
    Src Kinase inhibitor
    1-NA-PP1 is a selective inhibitor of v-Src and c-Fyn as well as c-Abl Learn More
  7. AMG-47a

    Catalog No. A13167
    Lck inhibitor
    AMG-47a is an orally bioavailable potent inhibitor of Lck and T cell proliferation. It exhibits anti-inflammatory activity (ED50 11 mg/kg) in the anti-CD3 induced production of IL-2 in mice. Learn More
  8. PP1 Analog II, 1NM-PP1

    Catalog No. A13573
    PP1 Analog II, 1NM-PP1 is a cell-permeable PP1 analog that acts as a potent and selective inhibitor of mutant kinases over their wild-type progenitors. Learn More
  9. CGP77675

    Catalog No. A13821
    Src inhibitor
    CGP77675 is a potent Src kinase inhibitor. CGP77675 inhibited phosphorylation of peptide substrates and autophosphorylation of purified Src (IC50: 5-20 and 40 nM, respectively). Learn More
  10. TG 100572

    Catalog No. A13820
    VEGFR2/Src inhibitor
    TG 100572 is VEGFR2 and Src kinase inhibitor. Learn More
  11. TG 100801

    Catalog No. A13819
    VEGFR2/Src inhibitor
    TG 100801 is a VEGFR2 targeting prodrug currently in a clinical trial. The active form is TG100572. Learn More
  12. A-419259

    Catalog No. A13290
    SFK inhibitor
    A-419259 is an inhibitor of Src family kinases (SFK) (IC50 = 0.1 - 0.3 uM). Learn More
  13. Lck Inhibitor

    Catalog No. A15140
    Lck Inhibitor
    Lck Inhibitor is a new class of compounds that are potent inhibitors of Lck with an IC50 value of 7 nM. Learn More
  14. Lck inhibitor 2

    Catalog No. A15141
    Lck inhibitor
    Lck inhibitor 2 is a bis-anilinopyrimidine inhibitor of tyrosine kinases including LCK, BTK, LYN, SYK, and TXK. The IC50 values are 13nM, 9nM, 3nM, 26nM and 2nM for Lck, Btk, Lyn, Btk and Txk respectively . Learn More
  15. Scutellarein

    Catalog No. A12234
    Scutellarin, a main active ingredient extracted from Erigeron breviscapus (Vant.) Hand-Mazz, has been wildly used to treat acute cerebral infarction and paralysis induced by cerebrovascular diseases. Learn More
  16. Tilfrinib

    Catalog No. A16086
    Brk inhibitor
    Tilfrinib is a potent and selective breast tumor kinase (Brk) inhibitor (IC50 = 3.15 nM). Learn More
  17. CPDA

    Catalog No. A16242
    SHIP2 inhibitor
    CPDA is a novel potent SHIP2 inhibitor that can effectively ameliorate insulin resistance in 3T3-L1 adipocytes. Learn More
  18. Lyn-IN-1

    Catalog No. A16265
    dual Bcr-Abl/Lyn inhibitor
    Lyn-IN-1 is a potent and selective dual Bcr-Abl/Lyn inhibitor, extracted from patent WO2014169128A1. Learn More
  19. PP121

    Catalog No. A11207
    PI3K Inhibitor
    PP121 is a dual inhibitor of receptor tyrosine kinases (RTKs) (IC50 < 0.02 μM for Abl, Src, VEGFR-2 and PDGFR) and PI 3-K family kinases (IC50 < 0.06 μM for p110α, DNA-PK and mTOR). Learn More
  20. KX2-391

    Catalog No. A11177
    Src inhibitor

    KX2-391 is a novel non-ATP competitive substrate-pocket directed SRC inhibitor.

    Learn More
  21. Quercetin (Sophoretin)

    Catalog No. A10766
    MAO-B inhibitor
    Quercetin inhibits many enzyme systems including tyrosine protein kinase, phospholipase A2, phosphodiesterases, mitochondrial ATPase, PI 3-kinase and protein kinase C. Learn More
  22. NVP-BHG712

    Catalog No. A10661
    EphB4 inhibitor
    NVP-BHG712 is a selective inhibitor of EphB4 kinase that exhibits selectivity for EphB4 over more than 40 other kinases in vitro, including FGFR3. Learn More
  23. Dasatinib (BMS-354825)

    Catalog No. A10290
    Abl-Src inhibitor
    Dasatinib (BMS-354825) is an oral multi- BCR/ABL and Src family tyrosine kinase inhibitor. The main targets of dasatinib, are BCR/ABL, Src, c-Kit, ephrin receptors, and several other tyrosine kinases, but not erbB kinases such as EGFR or Her2. Learn More
  24. Saracatinib (AZD0530)

    Catalog No. A10108
    Src/Abl inhibitor
    Saracatinib (AZD0530) is a highly selective, orally available, dual-specific Src/Abl kinase inhibitor with IC50 of 2.7 and 30 nM for c-Src and Abl kinase, respectively. Learn More
  25. TG 100572 HCl

    Catalog No. A15260
    VEGFR2/Src kinase inhibitor
    TG 100572 is a multi-targeted kinase inhibitor that inhibit select growth factor receptor tyrosine kinases and Src familt kinases with IC50 values of 2/7/2/1/0.5 nM for VEGFR1/VEGFR2/FGFR1/Src/Fyn kianse respectively. Learn More
  26. Dasatinib hydrochloride

    Catalog No. A15060
    Src inhibitor
    Dasatinib hydrochloride is a potent and dual Abl/ Src inhibitor IC50 of <1 nM/0.8 nM respectively; also inhibit c-Kit (WT)/c-Kit (D816V) with IC50 of 79 nM/37 nM. Learn More
  27. PD-166285

    Catalog No. A13868
    Src inhibitor
    PD 166285 is a potent inhibitor of the tyrosine kinases c-Src, Flg (fibroblast growth factor receptor 1, FGFR1). Learn More
  28. A419259

    Catalog No. A14323
    Src inhibitor
    A419259 trihydrochloride is an apoptosis inducing agent that inhibits Src family kinases (c-Src). Learn More
  29. WH 4-023

    Catalog No. A14117
    dual Lck/Src inhibitor
    WH-4-023 is a potent and selective dual Lck/Src inhibitor with IC50 of 2 nM/6 nM for Lck and Src kinase respectively. Learn More
  30. KX1-004

    Catalog No. A12214
    Src-PTK inhibitor
    KX1-004 is a potent small molecule inhibitor of Src-PTK as a potential protective drug for NIHL. Learn More
  31. SU6656

    Catalog No. A15518
    SRC inhibitor
    SU6656 is a selective inhibitor of Src kinases, Including Src, Yes, Lyn, and Fyn (IC50 = 280, 20, 130, 170 nM, respectively). Learn More
  32. KX2-391 2HCl

    Catalog No. A11471
    Src inhibitor
    KX2-391 2Hcl is the first clinical Src inhibitor (peptidomimetic class) that targets the peptide substrate site of Src, with GI50 of 9-60 nM in cancer cell lines. Learn More
  33. MCB-613

    Catalog No. A13415
    SRC stimulator
    MCB-613 is a potent, pan steroid receptor coactivator (SRC) stimulator. Learn More
  34. A-770041

    Catalog No. A11288
    Lck inhibitor
    A-770041 is selective and orally active Src-family Lck inhibitor; A-770041 is a 147 nM inhibitor of Lck (1 mM ATP) and is 300-fold selective against Fyn, the other Src family kinase involved in T-cell signaling. Learn More
  35. MNS

    Catalog No. A16240
    Src/Syk inhibitor
    MNS is a potent and selective inhibitor of Src and Syk tyrosine kinases. Learn More
  36. AZM475271

    Catalog No. A16241
    Src inhibitor
    AZM475271 is a potent and selective Src kinase inhibitor with IC50 of 5 nM; no inhibitory activity on Flt3, KDR, Tie-2. Learn More
  37. T338C Src-IN-1

    Catalog No. A16243
    Src inhibitor
    T338C Src-IN-1 is a potent mutant-Src T338C inhibitor; exhibited the most potent inhibition of T338C(IC50=111 nM) relative to WT c-Src (10-fold increase). Learn More
  38. T338C Src-IN-2

    Catalog No. A16244
    Src inhibitor
    T338C Src-IN-2 is a potent mutant c-Src T338C kinase inhibitor with IC50 of 317 nM; also inhibits T338C/V323A and T338C/V323S with IC50 of 57 nM/19 nM. Learn More
  39. Bosutinib (SKI-606)

    Catalog No. A10161
    Src inhibitor
    Bosutinib (SKI-606) is a tyrosine kinase inhibitor undergoing research for use in the treatment of cancer. Learn More

39 Item(s)

per page

Set Ascending Direction